Miao L - Search Results

1

Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes.

Hu Y, Wang Y, Shao T, Tang W, Hu K, Zhou Y, Miao L, Liu J, Wang B, Yu W. Hu Y, et al. Among authors: miao l. Vaccine. 2023 May 2;41(18):3003-3010. doi: 10.1016/j.vaccine.2023.03.056. Epub 2023 Mar 30. Vaccine. 2023. PMID: 37037708 Free PMC article.

2

Pulmonary Capillary Hemangioma-like Pulmonary Artery Hypertension Associated With Interferon-Alpha Therapy.

Wang Y, Zhou Y, Miao L. Wang Y, et al. Among authors: miao l. Am J Ther. 2020 Sep/Oct;27(5):e511-e514. doi: 10.1097/MJT.0000000000001141. Am J Ther. 2020. PMID: 31977566 No abstract available.

3

[A Review of Drug Therapy of Lung Cancer with Interstitial Lung Disease].

Wang Y, Zhou Y, Miao L. Wang Y, et al. Among authors: miao l. Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):286-293. doi: 10.3779/j.issn.1009-3419.2020.102.01. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32316717 Free PMC article. Review. Chinese.

4

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Wang Y, Miao L, Hu Y, Zhou Y. Wang Y, et al. Among authors: miao l. Front Oncol. 2020 Sep 8;10:1636. doi: 10.3389/fonc.2020.01636. eCollection 2020. Front Oncol. 2020. PMID: 33014824 Free PMC article.

5

Nivolumab in combination with anlotinib achieved remarkable efficacy in a patient with driver-negative lung squamous cell carcinoma and PS of 4.

Wang Y, Zhang Q, Miao L, Zhou Y. Wang Y, et al. Among authors: miao l. Ann Palliat Med. 2020 Nov;9(6):4384-4388. doi: 10.21037/apm-20-2096. Ann Palliat Med. 2020. PMID: 33302689 Free article.

6

Can Immunotherapy Combined With Antiangiogenic Therapy Be a Breakthrough for Driver-Negative Non-small-Cell Lung Cancer Patients With Performance Status of 3-4 in the First-Line Setting?

Wang Y, Zhou Y, Miao L. Wang Y, et al. Among authors: miao l. Am J Ther. 2020 Dec 28. doi: 10.1097/MJT.0000000000001305. Online ahead of print. Am J Ther. 2020. PMID: 33395049 No abstract available.

7

Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor in a patient with recurrent non-small cell lung cancer: A case report.

Zhang QN, Li Y, Zhao Q, Tian M, Chen LL, Miao LY, Zhou YJ. Zhang QN, et al. Thorac Cancer. 2021 May;12(10):1617-1619. doi: 10.1111/1759-7714.13947. Epub 2021 Mar 24. Thorac Cancer. 2021. PMID: 33760389 Free PMC article.

8

Association of Brain Metastases With Immune Checkpoint Inhibitors Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.

Wang Y, Zhang Q, Chen C, Hu Y, Miao L, Zhou Y. Wang Y, et al. Among authors: miao l. Front Oncol. 2021 Dec 8;11:721760. doi: 10.3389/fonc.2021.721760. eCollection 2021. Front Oncol. 2021. PMID: 34956860 Free PMC article.

9

Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer.

Wang Y, Gong X, Hu Y, Yi Q, Zhang Q, Miao L, Zhou Y. Wang Y, et al. Among authors: miao l. Front Oncol. 2022 Jun 20;12:873709. doi: 10.3389/fonc.2022.873709. eCollection 2022. Front Oncol. 2022. PMID: 35795057 Free PMC article.

10

The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis.

Zhang Q, Gong X, Sun L, Miao L, Zhou Y. Zhang Q, et al. Among authors: miao l. Front Oncol. 2022 Jul 18;12:791496. doi: 10.3389/fonc.2022.791496. eCollection 2022. Front Oncol. 2022. PMID: 35924149 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,659 results

Search Page

Filters